Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81
Published January 25, 2017 · Recall initiated: December 2, 2016
Summary
FDA records drug Class III recall D-0432-2017, published January 25, 2017 and initiated December 2, 2016. Recalling firm: Shire PLC; Status: Terminated; Reported quantity: 4,520 bottles; Lot: Lot Number AE7363A, exp 06/30/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules
What to do
Voluntary: Firm initiated
Get an email if PENTASA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PENTASA
- Manufacturer
- Shire PLC
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0354092191123
- Lot
- Lot Number AE7363A, exp 06/30/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARisedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19),January 25, 2017
- FDANovacort Gel Sample Packets (2% hydrocortisone acetate, 1% pramoxine HCl), 10-count Carton of 1.0 g sampleJanuary 25, 2017
- FDAClindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g tubes, Rx Only, Manufactured by Perrigo,January 25, 2017
- FDADonepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-countJanuary 25, 2017
- FDAOPT Croutons is a synthetic bone substitute designed for the repair of bony defects and is made of pureJanuary 18, 2017
- FDAMinibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free Intended use: For theJanuary 18, 2017
Questions about this recall
Was Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81 recalled?
Yes. FDA published recall D-0432-2017 on January 25, 2017. Reported hazard: Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PENTASA. UPC: 0354092191123.